Skip to content
NJ News HubNewsHub

Health

Valley Hospital first in U.S. to use AI-powered tool to enhance heart stenting procedures

Source: ROI-NJ · Jul 27, 2026, 10:28 AM

AI-assisted briefing from the publisher’s public headline and excerpt — not original reporting. How we write briefings

Valley Hospital first in U.S. to use AI-powered tool to enhance heart stenting procedures news image

Valley Hospital has become the first hospital in the United States to deploy Heartflow PCI Navigator outside of a clinical trial setting.

This AI-powered software tool provides cardiologists with enhanced visualization of patient anatomy prior to performing coronary angioplasty procedures, which are used to open narrowed or blocked coronary arteries in patients with coronary artery disease.

The technology represents a significant advancement in interventional cardiology, offering physicians new insights to improve procedural planning and patient outcomes.

Key points

  • Valley Hospital is the first U.S. hospital to use Heartflow PCI Navigator in routine clinical practice outside research studies
  • The AI-powered software provides cardiologists with advanced anatomical insights before coronary angioplasty procedures
  • The tool helps open narrowed or blocked coronary arteries in coronary artery disease patients
  • This represents a significant advancement in interventional cardiology and procedural planning

FAQ

What is Heartflow PCI Navigator?
Heartflow PCI Navigator is an AI-powered software tool that gives cardiologists detailed insights into a patient's heart anatomy before performing coronary angioplasty procedures, helping improve procedural planning and outcomes.
What is coronary angioplasty?
Coronary angioplasty is a medical procedure designed to open narrowed or blocked coronary arteries in patients with coronary artery disease, restoring blood flow to the heart.
Why is Valley Hospital's use of this tool significant?
Valley Hospital is the first hospital in the United States to use this advanced AI technology in routine clinical practice outside of controlled clinical trials, marking a major milestone in cardiology care.

Briefing prepared for NJ News Hub. Verify details on the original story. See our editorial policy.

Related